- Apply for a Grant
Our Grants
- Funding What Matters
- AGHF Funded Proposals
Award Details
AGHF will award up to $300,000 in direct costs each award cycle. This award may go to a single application or multiple depending on the quality, quantity, and diversity of the proposals received each cycle. Proposals should be for projects with timelines between 1 and 3 years and focused on prospective human subjects’ research in the pre-clinical or translational phases. Applicants should be affiliated with an academic medical institution where patients with congenital heart disease are cared for, and the principal investigators hold a doctoral-level degree. Proposals for multiple principal investigators will be considered but for award distribution, a single contact investigator and corresponding institution shall be named.
Only complete applications that are submitted on time will be reviewed. Only one proposal per year is allowed per investigator. Resubmissions are allowed up to two occurrences with 12-months in between. Proposals are to be submitted in a single composite PDF to XXX and must adhere to Ariel 11-pt font and no more than 1-inch margins. Indirect costs will not be allowed.
Funded proposals will be expected to submit a yearly progress report and detailed accounting of funds. Progress reports should include an update on all progress to-date for each proposed aim. Any challenges or barriers should be outlined, especially if they may impact the project end and final analysis. Any publications resulting from the proposed work will acknowledge the support of AGHF. If additional funding is obtained for a funded proposal, the principal investigator must submit the details in writing to AGHF to determine if AGHF funds must be returned.
Application Requirements
- 1. Face Page
- ○ Face Page will include the proposal title, contact principal investigator name and contact information, institution, proposed project period, and institutional contact or grant officer.
- 2. Curriculum Vitae and NIH Biosketch of Principal Investigator
- 3. Lay Summary
- ○ Not to exceed 1 page
- 4. Impact Statement & Tie to A Giving Heart Foundation
- ○ Not to exceed 1⁄2 page
- ○ Clearly state how the research will directly or indirectly benefit infants and children with CHD.
- 5. Detailed Budget
- ○ Excel budget with detailed year-by-year proposed expenses
- ○ Further guidelines below
- 6. Detailed Budget Justification
- ○ If your proposal contains a subaward, please also included a signed subrecipient commitment form following your detailed justification.
- 7. Scientific Proposal/Research Plan (up to 12 pages)
- ○ Specific Aims not to exceed 1 page
- ○ Project timeline and milestones not to exceed 1 page
- ○ Scientific approach not to exceed 5 pages
- ■ If human subjects are going to be included, please outline the process for obtaining informed consent, including any vulnerable populations. If the proposal is selected for funding, AGHF will request proof of IRB review and approval.
- 8. References not to exceed 5 pages
- 9. Please provide a robust plan for translating research outcomes to clinical practice.
Budget Details
- • Renovation and/or construction of office or lab space
- • Entertainment
- • Insurance
- • Taxes
- • Tuition
Terms of Grant/Use
Upon notification of award dollars, investigators are asked to confirm the acceptance of the dollars within 10 business days of notification. Once written acceptance is received, the awarded investigator and institution will receive a written award letter detailing the terms of the grant. These letters must be signed by the investigator, authorized institutional signer, and a representative from AGHF. This signed letter is an agreement of funding terms and expectations.
AGHF is honored to support research that will impact the lives of children with CHD. We request that AGHF-funded investigators properly cite the Foundation on any relevant project output such as publications, presentations, or abstracts.
Progress reports are required, and details can be found above. Additionally, AGHF is very interested in the final outcome of your project and any additional work or products that result from our award. We request a final report once the final analysis is complete, no more than 1- year following award end date) and any subsequent updates.
Some of the projects that AGHF will fund may be very early investments in the development of commercial products. AGHF may expect to enter into a revenue-sharing agreement where any future commercialization derived from the funded research will provide a return to the foundation to support future projects. Details and negotiations will be discussed and shared for relevant proposals and terms outlined in award letters.